Biohaven (BHVN) Net Equity Issued and Repurchased (2023 - 2026)

Biohaven has reported Net Equity Issued and Repurchased for 4 years, with the latest figure at $178.9 million in Q1 2026.

• Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $178.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $368.1 million (down 37.71% YoY) and the FY2025 annual result came in at $189.2 million, down 71.6% from the prior year.
• Net Equity Issued and Repurchased retreated to $178.9 million in Q1 2026 per BHVN's latest filing, from $189.2 million in the prior quarter.
• Over five years, Net Equity Issued and Repurchased peaked at $271.3 million in Q4 2024 and troughed at $76.4 million in Q3 2024.
• A 4-year average of $191.8 million and a median of $189.2 million in 2025 frame the typical range for Net Equity Issued and Repurchased.
• The sharpest annual moves came in 2024 and 2025: Net Equity Issued and Repurchased climbed 11.54% in 2024, then plunged 30.27% in 2025.
• Over 4 years, Net Equity Issued and Repurchased stood at $243.2 million in 2023, then increased by 11.54% to $271.3 million in 2024, then slumped by 30.27% to $189.2 million in 2025, then declined by 5.44% to $178.9 million in 2026.
• According to Business Quant data, Net Equity Issued and Repurchased over the past three periods registered $178.9 million, $189.2 million, and $271.3 million for Q1 2026, Q4 2025, and Q4 2024 respectively.